RARA and acute promyelocytic leukemia: Although RARα was initially shown to be an oncogenic driver as a fusion product of promyelocytic leukemia (PML) and RARA genes in acute promyelocytic leukemia (APL) 9, recent reports have demonstrated that native RARα possesses oncogenic properties itself 10-14.